A Systematic Review and Meta-analysis of the Prevalence and Impact of Pulmonary Bacterial Colonisation in Stable State Chronic Obstructive Pulmonary Disease (COPD)

被引:10
|
作者
Armitage, Michael N. [1 ]
Spittle, Daniella A. [2 ]
Turner, Alice M. [3 ]
机构
[1] Univ Hosp Coventry & Warwickshire NHS Trust, Med Educ, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England
[2] Univ Birmingham, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England
[3] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Inst Appl Hlth Res, Birmingham B15 2TT, W Midlands, England
关键词
COPD; chronic bronchitis; emphysema; stable; colonisation; prevalence; BRONCHIAL COLONIZATION; AIRWAY INFLAMMATION; HAEMOPHILUS-INFLUENZAE; INFECTION; EXACERBATIONS; MICROBIOME; FREQUENCY; SEVERITY; SMOKERS; PROTEIN;
D O I
10.3390/biomedicines10010081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Half of acute exacerbations of COPD are due to bacterial infection, and the other half are likely influenced by microbial colonisation. The same organisms commonly cultured during acute exacerbations are often found in the sputum of patients during stability. A robust assessment of the prevalence of potentially pathogenic microorganisms (PPMs) in the sputum of stable COPD patients may help to inform the targeted prevention of exacerbation by these organisms. Methods: A systematic review and meta-analysis was carried out to determine the prevalence of PPMs in patients with COPD in the stable state. Meta-analysis of prevalence was carried out using the Freeman-Tukey double arcsine transformation random effects model, and sub-group analysis was performed for sputum modality. Prevalence of total and individual PPMs was calculated from patient-level data from individual studies. Results: Pooled prevalence of PPMs identified by sputum culture was found to be 41% (95% CI 36-47%). Significant heterogeneity was found across all studies, which can likely be attributed to inconsistent measuring and reporting of PPMs. The most commonly reported organisms were H. influenzae, M catarrhalis, S. pneumoniae, S. aureus, and P. aeruginosa. Declining lung function was weakly correlated with prevalence of PPMs. Conclusion: The airways of patients with COPD are colonised with PPMs during the stable state in almost half of patients. A complex relationship likely exists between the microbiome in the stable state and the phenotype of COPD patients. Targeted microbial therapy for preventing exacerbations of COPD should carefully consider the stable microbiome as well as the exacerbated.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
    Nadia AL Wachami
    Morad Guennouni
    Younes Iderdar
    Karima Boumendil
    Maryem Arraji
    Yassmine Mourajid
    Fatima Zahra Bouchachi
    Mohamed Barkaoui
    Mohamed Lahbib Louerdi
    Abderraouf Hilali
    Mohamed Chahboune
    BMC Public Health, 24
  • [2] Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
    AL Wachami, Nadia
    Guennouni, Morad
    Iderdar, Younes
    Boumendil, Karima
    Arraji, Maryem
    Mourajid, Yassmine
    Bouchachi, Fatima Zahra
    Barkaoui, Mohamed
    Louerdi, Mohamed Lahbib
    Hilali, Abderraouf
    Chahboune, Mohamed
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [3] Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis
    Varmaghani, Mehdi
    Dehghani, Mina
    Heidari, Elham
    Sharifi, Farshad
    Moghaddam, Sahar Saeedi
    Farzadfar, Farshad
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2019, 25 (01) : 47 - 57
  • [4] Prevalence of chronic obstructive pulmonary disease in India: A systematic review and meta-analysis
    Daniel, Roy Arokiam
    Aggarwal, Praveen
    Kalaivani, Mani
    Gupta, Sanjeev Kumar
    LUNG INDIA, 2021, 38 (06) : 506 - 513
  • [5] The Prevalence and Risk Factors of Osteoporosis in Individuals with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis
    Chen, Y.
    Ramsook, A. H.
    Coxson, H. O.
    Bon, J. M.
    Reid, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis
    Chen, Xuesong
    Tang, Shaowen
    Liu, Kouying
    Li, Qinling
    Kong, Hui
    Zeng, Xiaoning
    Xie, Weiping
    Wang, Hong
    JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : 309 - 319
  • [7] Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol
    Kefala, Anastasia M.
    Fortescue, Rebecca
    Alimani, Gioulinta S.
    Kanavidis, Prodromos
    McDonnell, Melissa Jane
    Magiorkinis, Emmanouil
    Megremis, Spyridon
    Paraskevis, Dimitrios
    Voyiatzaki, Chrysa
    Mathioudakis, Georgios A.
    Papageorgiou, Effie
    Papadopoulos, Nikolaos G.
    Vestbo, Jorgen
    Beloukas, Apostolos
    Mathioudakis, Alexander G.
    BMJ OPEN, 2020, 10 (04):
  • [8] Prevalence of exacerbated chronic obstructive pulmonary disease with comorbid pulmonary hypertension: a systematic review and meta-analysis
    Oktaviani, Yani
    Ilyas, Muh
    Yunus, Faisal
    Walenna, Nirwana F.
    Tabri, Nur A.
    Santoso, Arif
    Natsir, Bulkis
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2023, 182 (09) : 566 - 573
  • [9] Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
    Zinellu, Elisabetta
    Zinellu, Angelo
    Pau, Maria Carmina
    Piras, Barbara
    Fois, Alessandro G.
    Mellino, Sabrina
    Carru, Ciriaco
    Mangoni, Arduino A.
    Pirina, Pietro
    ANTIOXIDANTS, 2021, 10 (11)
  • [10] Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A systematic review with meta-analysis
    Rodrigo, Gustavo J.
    Nannini, Luis J.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (05) : 495 - 502